Paton is the director of Manaaki Manawa, the Centre for Heart Research at the University of Auckland, where he is leading ...

An expert in connective tissue disease–associated interstitial lung disease described best approaches for rheumatologists to ...

Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as ...

Our collaborative approach integrates these sophisticated technologies to drive innovative research, making a significant impact on the future of Rheumatic and Musculoskeletal Diseases. Join us for ...

Credit: Dr Salahuddin Kazi, MD, comments on the challenges of diagnosing seronegative rheumatic diseases and discusses a ...

World Young Rheumatic Diseases Day is being observed today to raise awareness about rheumatic diseases in children and young ...

Aberrant B-cell function, which could arise from various underlying causes, is central to the pathogenesis of diverse ...

A new study, published today in mBio, employed a novel strategy to halt progression of rheumatic heart disease in a preclinical model by using low-dose interleukin 2 (LD-IL-2). IL-2 is a hormone of ...

Jamuna Patil, Ravindra Sharma and Madhavi Kakade, (names changed) suffered from severe aches, pains and swollen joints for years before they were diagnosed with arthritis or joint inflammation and ...

Children with rheumatic diseases face increased risks for COVID-19-related hospitalization, though the use of tumor necrosis factor-alpha inhibitors may offer protective benefits. Children with ...

Autoimmune rheumatic diseases such as rheumatoid arthritis, lupus and vasculitis are chronic inflammatory disorders that affect the immune system and can damage organs and tissues throughout the body.